Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium

The differentiation-inducing factor-1 (DIF-1) isolated from Dictyostelium discoideum is a potent antiproliferative agent that induces growth arrest and differentiation in mammalian cells in vitro. However, the specific target molecule(s) of DIF-1 has not been identified. In this study, we have tried...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer research (Chicago, Ill.) Ill.), 2004-04, Vol.64 (7), p.2568-2571
Hauptverfasser: SHIMIZU, Kasumi, MURATA, Taku, TAGAWA, Toshiro, TAKAHASHI, Katsunori, ISHIKAWA, Ryoki, ABE, Yumiko, HOSAKA, Kohei, KUBOHARA, Yuzuru
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2571
container_issue 7
container_start_page 2568
container_title Cancer research (Chicago, Ill.)
container_volume 64
creator SHIMIZU, Kasumi
MURATA, Taku
TAGAWA, Toshiro
TAKAHASHI, Katsunori
ISHIKAWA, Ryoki
ABE, Yumiko
HOSAKA, Kohei
KUBOHARA, Yuzuru
description The differentiation-inducing factor-1 (DIF-1) isolated from Dictyostelium discoideum is a potent antiproliferative agent that induces growth arrest and differentiation in mammalian cells in vitro. However, the specific target molecule(s) of DIF-1 has not been identified. In this study, we have tried to identify the target molecule(s) of DIF-1 in mammalian cells, examining the effects of DIF-1 and its analogs on the activity of some candidate enzymes. DIF-1 at 10-40 micro M dose-dependently suppressed cell growth and increased the intracellular cyclic AMP concentration in K562 leukemia cells. It was then found that DIF-1 at 0.5-20 micro M inhibited the calmodulin (CaM)-dependent cyclic nucleotide phosphodiesterase (PDE1) in vitro in a dose-dependent manner. Kinetic analysis revealed that DIF-1 acted as a competitive inhibitor of PDE1 versus the substrate cyclic AMP. Because DIF-1 did not significantly affect the activity of other PDEs or CaM-dependent enzymes and, in addition, an isomer of DIF-1 was a less potent inhibitor, we have concluded that PDE1 is a pharmacological and specific target of DIF-1.
doi_str_mv 10.1158/0008-5472.CAN-03-3551
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71792431</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71792431</sourcerecordid><originalsourceid>FETCH-LOGICAL-c434t-43d64520e775033b9a269520e168a6b245ae0916a81cf2e9e009a902a0149ea03</originalsourceid><addsrcrecordid>eNpNkc-OFCEQh4nRuOPqI2i4aDSRFRroHo6b2fVPslEPeu7UQPWIoWEE-jBv5SNKZydqAiEVvqpf4CPkueBXQujtO875lmk1dFe768-MSya1Fg_IRmi5ZYNS-iHZ_GUuyJNSfrZSC64fkwuhuTZGyA35vYMwJ7cEH5nDI0aHsVJ7ssFbGhcbMFXvkB5_pNK281gqZihIX3-9uRVvqC8U2i3kGWwK6eAtBFohH7DSNFHnpwlzm-mh-hSZj26xPh7oBLamzMRbCrGt6usyp0zhsOb7kgJUdHTKaaY33tZTarnBL_NT8miCUPDZ-bwk39_fftt9ZHdfPnzaXd8xq6SqTEnXK91xHAbNpdwb6Hqz1qLfQr_vlAbkRvSwFXbq0CDnBgzvgAtlELi8JK_u5x5z-rW0V4-zLxZDgIhpKeMgBtMpKRqo70GbUykZp_GY_Qz5NAo-rqrGVcO4ahibqpHLcVXV-l6cA5b9jO5f19lNA16eASjtU6cM0fryH9dzJQYt_wA9Q59M</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71792431</pqid></control><display><type>article</type><title>Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium</title><source>MEDLINE</source><source>American Association for Cancer Research</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>SHIMIZU, Kasumi ; MURATA, Taku ; TAGAWA, Toshiro ; TAKAHASHI, Katsunori ; ISHIKAWA, Ryoki ; ABE, Yumiko ; HOSAKA, Kohei ; KUBOHARA, Yuzuru</creator><creatorcontrib>SHIMIZU, Kasumi ; MURATA, Taku ; TAGAWA, Toshiro ; TAKAHASHI, Katsunori ; ISHIKAWA, Ryoki ; ABE, Yumiko ; HOSAKA, Kohei ; KUBOHARA, Yuzuru</creatorcontrib><description>The differentiation-inducing factor-1 (DIF-1) isolated from Dictyostelium discoideum is a potent antiproliferative agent that induces growth arrest and differentiation in mammalian cells in vitro. However, the specific target molecule(s) of DIF-1 has not been identified. In this study, we have tried to identify the target molecule(s) of DIF-1 in mammalian cells, examining the effects of DIF-1 and its analogs on the activity of some candidate enzymes. DIF-1 at 10-40 micro M dose-dependently suppressed cell growth and increased the intracellular cyclic AMP concentration in K562 leukemia cells. It was then found that DIF-1 at 0.5-20 micro M inhibited the calmodulin (CaM)-dependent cyclic nucleotide phosphodiesterase (PDE1) in vitro in a dose-dependent manner. Kinetic analysis revealed that DIF-1 acted as a competitive inhibitor of PDE1 versus the substrate cyclic AMP. Because DIF-1 did not significantly affect the activity of other PDEs or CaM-dependent enzymes and, in addition, an isomer of DIF-1 was a less potent inhibitor, we have concluded that PDE1 is a pharmacological and specific target of DIF-1.</description><identifier>ISSN: 0008-5472</identifier><identifier>EISSN: 1538-7445</identifier><identifier>DOI: 10.1158/0008-5472.CAN-03-3551</identifier><identifier>PMID: 15059913</identifier><identifier>CODEN: CNREA8</identifier><language>eng</language><publisher>Philadelphia, PA: American Association for Cancer Research</publisher><subject>Antineoplastic agents ; Binding, Competitive ; Biological and medical sciences ; Cyclic AMP - metabolism ; Cyclic Nucleotide Phosphodiesterases, Type 1 ; Hexanones - metabolism ; Hexanones - pharmacology ; Humans ; K562 Cells ; Medical sciences ; Pharmacology. Drug treatments ; Phosphodiesterase Inhibitors - metabolism ; Phosphodiesterase Inhibitors - pharmacology ; Phosphoric Diester Hydrolases - metabolism ; Tumors</subject><ispartof>Cancer research (Chicago, Ill.), 2004-04, Vol.64 (7), p.2568-2571</ispartof><rights>2004 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c434t-43d64520e775033b9a269520e168a6b245ae0916a81cf2e9e009a902a0149ea03</citedby><cites>FETCH-LOGICAL-c434t-43d64520e775033b9a269520e168a6b245ae0916a81cf2e9e009a902a0149ea03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,3343,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=15604175$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15059913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SHIMIZU, Kasumi</creatorcontrib><creatorcontrib>MURATA, Taku</creatorcontrib><creatorcontrib>TAGAWA, Toshiro</creatorcontrib><creatorcontrib>TAKAHASHI, Katsunori</creatorcontrib><creatorcontrib>ISHIKAWA, Ryoki</creatorcontrib><creatorcontrib>ABE, Yumiko</creatorcontrib><creatorcontrib>HOSAKA, Kohei</creatorcontrib><creatorcontrib>KUBOHARA, Yuzuru</creatorcontrib><title>Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium</title><title>Cancer research (Chicago, Ill.)</title><addtitle>Cancer Res</addtitle><description>The differentiation-inducing factor-1 (DIF-1) isolated from Dictyostelium discoideum is a potent antiproliferative agent that induces growth arrest and differentiation in mammalian cells in vitro. However, the specific target molecule(s) of DIF-1 has not been identified. In this study, we have tried to identify the target molecule(s) of DIF-1 in mammalian cells, examining the effects of DIF-1 and its analogs on the activity of some candidate enzymes. DIF-1 at 10-40 micro M dose-dependently suppressed cell growth and increased the intracellular cyclic AMP concentration in K562 leukemia cells. It was then found that DIF-1 at 0.5-20 micro M inhibited the calmodulin (CaM)-dependent cyclic nucleotide phosphodiesterase (PDE1) in vitro in a dose-dependent manner. Kinetic analysis revealed that DIF-1 acted as a competitive inhibitor of PDE1 versus the substrate cyclic AMP. Because DIF-1 did not significantly affect the activity of other PDEs or CaM-dependent enzymes and, in addition, an isomer of DIF-1 was a less potent inhibitor, we have concluded that PDE1 is a pharmacological and specific target of DIF-1.</description><subject>Antineoplastic agents</subject><subject>Binding, Competitive</subject><subject>Biological and medical sciences</subject><subject>Cyclic AMP - metabolism</subject><subject>Cyclic Nucleotide Phosphodiesterases, Type 1</subject><subject>Hexanones - metabolism</subject><subject>Hexanones - pharmacology</subject><subject>Humans</subject><subject>K562 Cells</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphodiesterase Inhibitors - metabolism</subject><subject>Phosphodiesterase Inhibitors - pharmacology</subject><subject>Phosphoric Diester Hydrolases - metabolism</subject><subject>Tumors</subject><issn>0008-5472</issn><issn>1538-7445</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkc-OFCEQh4nRuOPqI2i4aDSRFRroHo6b2fVPslEPeu7UQPWIoWEE-jBv5SNKZydqAiEVvqpf4CPkueBXQujtO875lmk1dFe768-MSya1Fg_IRmi5ZYNS-iHZ_GUuyJNSfrZSC64fkwuhuTZGyA35vYMwJ7cEH5nDI0aHsVJ7ssFbGhcbMFXvkB5_pNK281gqZihIX3-9uRVvqC8U2i3kGWwK6eAtBFohH7DSNFHnpwlzm-mh-hSZj26xPh7oBLamzMRbCrGt6usyp0zhsOb7kgJUdHTKaaY33tZTarnBL_NT8miCUPDZ-bwk39_fftt9ZHdfPnzaXd8xq6SqTEnXK91xHAbNpdwb6Hqz1qLfQr_vlAbkRvSwFXbq0CDnBgzvgAtlELi8JK_u5x5z-rW0V4-zLxZDgIhpKeMgBtMpKRqo70GbUykZp_GY_Qz5NAo-rqrGVcO4ahibqpHLcVXV-l6cA5b9jO5f19lNA16eASjtU6cM0fryH9dzJQYt_wA9Q59M</recordid><startdate>20040401</startdate><enddate>20040401</enddate><creator>SHIMIZU, Kasumi</creator><creator>MURATA, Taku</creator><creator>TAGAWA, Toshiro</creator><creator>TAKAHASHI, Katsunori</creator><creator>ISHIKAWA, Ryoki</creator><creator>ABE, Yumiko</creator><creator>HOSAKA, Kohei</creator><creator>KUBOHARA, Yuzuru</creator><general>American Association for Cancer Research</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20040401</creationdate><title>Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium</title><author>SHIMIZU, Kasumi ; MURATA, Taku ; TAGAWA, Toshiro ; TAKAHASHI, Katsunori ; ISHIKAWA, Ryoki ; ABE, Yumiko ; HOSAKA, Kohei ; KUBOHARA, Yuzuru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c434t-43d64520e775033b9a269520e168a6b245ae0916a81cf2e9e009a902a0149ea03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Antineoplastic agents</topic><topic>Binding, Competitive</topic><topic>Biological and medical sciences</topic><topic>Cyclic AMP - metabolism</topic><topic>Cyclic Nucleotide Phosphodiesterases, Type 1</topic><topic>Hexanones - metabolism</topic><topic>Hexanones - pharmacology</topic><topic>Humans</topic><topic>K562 Cells</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphodiesterase Inhibitors - metabolism</topic><topic>Phosphodiesterase Inhibitors - pharmacology</topic><topic>Phosphoric Diester Hydrolases - metabolism</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SHIMIZU, Kasumi</creatorcontrib><creatorcontrib>MURATA, Taku</creatorcontrib><creatorcontrib>TAGAWA, Toshiro</creatorcontrib><creatorcontrib>TAKAHASHI, Katsunori</creatorcontrib><creatorcontrib>ISHIKAWA, Ryoki</creatorcontrib><creatorcontrib>ABE, Yumiko</creatorcontrib><creatorcontrib>HOSAKA, Kohei</creatorcontrib><creatorcontrib>KUBOHARA, Yuzuru</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer research (Chicago, Ill.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SHIMIZU, Kasumi</au><au>MURATA, Taku</au><au>TAGAWA, Toshiro</au><au>TAKAHASHI, Katsunori</au><au>ISHIKAWA, Ryoki</au><au>ABE, Yumiko</au><au>HOSAKA, Kohei</au><au>KUBOHARA, Yuzuru</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium</atitle><jtitle>Cancer research (Chicago, Ill.)</jtitle><addtitle>Cancer Res</addtitle><date>2004-04-01</date><risdate>2004</risdate><volume>64</volume><issue>7</issue><spage>2568</spage><epage>2571</epage><pages>2568-2571</pages><issn>0008-5472</issn><eissn>1538-7445</eissn><coden>CNREA8</coden><abstract>The differentiation-inducing factor-1 (DIF-1) isolated from Dictyostelium discoideum is a potent antiproliferative agent that induces growth arrest and differentiation in mammalian cells in vitro. However, the specific target molecule(s) of DIF-1 has not been identified. In this study, we have tried to identify the target molecule(s) of DIF-1 in mammalian cells, examining the effects of DIF-1 and its analogs on the activity of some candidate enzymes. DIF-1 at 10-40 micro M dose-dependently suppressed cell growth and increased the intracellular cyclic AMP concentration in K562 leukemia cells. It was then found that DIF-1 at 0.5-20 micro M inhibited the calmodulin (CaM)-dependent cyclic nucleotide phosphodiesterase (PDE1) in vitro in a dose-dependent manner. Kinetic analysis revealed that DIF-1 acted as a competitive inhibitor of PDE1 versus the substrate cyclic AMP. Because DIF-1 did not significantly affect the activity of other PDEs or CaM-dependent enzymes and, in addition, an isomer of DIF-1 was a less potent inhibitor, we have concluded that PDE1 is a pharmacological and specific target of DIF-1.</abstract><cop>Philadelphia, PA</cop><pub>American Association for Cancer Research</pub><pmid>15059913</pmid><doi>10.1158/0008-5472.CAN-03-3551</doi><tpages>4</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0008-5472
ispartof Cancer research (Chicago, Ill.), 2004-04, Vol.64 (7), p.2568-2571
issn 0008-5472
1538-7445
language eng
recordid cdi_proquest_miscellaneous_71792431
source MEDLINE; American Association for Cancer Research; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Antineoplastic agents
Binding, Competitive
Biological and medical sciences
Cyclic AMP - metabolism
Cyclic Nucleotide Phosphodiesterases, Type 1
Hexanones - metabolism
Hexanones - pharmacology
Humans
K562 Cells
Medical sciences
Pharmacology. Drug treatments
Phosphodiesterase Inhibitors - metabolism
Phosphodiesterase Inhibitors - pharmacology
Phosphoric Diester Hydrolases - metabolism
Tumors
title Calmodulin-dependent cyclic nucleotide phosphodiesterase (PDE1) is a pharmacological target of differentiation-inducing factor-1, an antitumor agent isolated from Dictyostelium
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T16%3A28%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Calmodulin-dependent%20cyclic%20nucleotide%20phosphodiesterase%20(PDE1)%20is%20a%20pharmacological%20target%20of%20differentiation-inducing%20factor-1,%20an%20antitumor%20agent%20isolated%20from%20Dictyostelium&rft.jtitle=Cancer%20research%20(Chicago,%20Ill.)&rft.au=SHIMIZU,%20Kasumi&rft.date=2004-04-01&rft.volume=64&rft.issue=7&rft.spage=2568&rft.epage=2571&rft.pages=2568-2571&rft.issn=0008-5472&rft.eissn=1538-7445&rft.coden=CNREA8&rft_id=info:doi/10.1158/0008-5472.CAN-03-3551&rft_dat=%3Cproquest_cross%3E71792431%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71792431&rft_id=info:pmid/15059913&rfr_iscdi=true